New Bayesian Method Detects Drug-Resistant Cancer Earlier by Analyzing Faint Circulating Tumor DNA Signals
Researchers have introduced Span, a censored-Poisson Bayesian model designed to detect early signs of drug resistance in circulating tumour DNA (ctDNA) before conventional assays can reliably measure them. The method reframes non-detects in serial liquid biopsy data as informative left-censored observations rather than absences of signal, accumulating evidence of tumour subclone growth over time. On synthetic data mimicking HR+/HER2- metastatic breast cancer patients on CDK4/6-inhibitor therapy, Span roughly doubled the detection rate of impending disease progression three months in advance compared to standard snapshot approaches.
Span is a parameter-free Bayesian change-point detector that models the flickering pattern of faint detects and non-detects in serial ctDNA liquid biopsy data, treating each non-detect as a left-censored observation rather than a null result. The algorithm accumulates a sequential generalised-likelihood-ratio statistic to identify upward shifts in per-variant detection rates, raising a competing-risks alarm with calibrated false-alarm control. In simulations of HR+/HER2- metastatic breast cancer patients on first-line CDK4/6-inhibitor plus endocrine therapy, Span achieved approximately 25% sensitivity for catching impending progressions three months ahead versus 11% for a standard snapshot approach, at a matched 10% false-alarm rate. Critically, the gain was specific to indolent tumour emergence — where subclones grow slowly and spend more time near the limit of detection — and vanished for fast-emerging resistance, providing a falsifiable dose-response relationship. The authors validated the survival modelling backbone on two real-world datasets (GBSG-2 breast cancer cohort and PBC2 longitudinal cohort), where the pipeline performed comparably to established Cox regression baselines and correctly declined to outperform on data where its mechanism should not apply. Because Span has no learned weights, it is not susceptible to overfitting, though all ctDNA trajectories used in the primary analysis are synthetic.
What's missing
All ctDNA trajectories are synthetic, meaning the core performance claims have not yet been validated on real patient liquid biopsy data; prospective clinical validation is entirely absent. The generalisability of the 10% false-alarm rate calibration to real-world assay variability and patient heterogeneity remains an open question.
What different sources said
- arXiv cs.LGCenter
Seeing Below the Limit of Detection: A Censored-Poisson Bayesian Latent-Growth Change-Point Detector (the Span Detector) for Serial ctDNA in HR+/HER2- Metastatic Breast Cancer
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.